Funder: Alliance for Cancer Gene Therapy
Due Dates (Anticipated): May 2026 (LOI/abstract) | August 2026 (Full application)
Funding Amounts: Up to $500,000 total over 2–3 years; max 10% indirect costs.
Summary: Supports innovative cell and gene therapy research for gynecological cancers, targeting scientific barriers and advancing novel therapeutic strategies.